isoxazoles has been researched along with Nervous System Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Q; Jia, A; Ma, W; Wang, Y | 1 |
| Janszky, J | 1 |
| Madhusoodanan, S; Zaveri, D | 1 |
| Perrone, MG; Scilimati, A; Simone, L; Vitale, P | 1 |
| Backonja, MM | 1 |
| Berg, M; Bruhn, T; Diemer, NH; Johansen, FF; Krogsgaard-Larsen, P | 1 |
| Allen, SD; Kinsolving, CR; Mitchell, JT; Mullen, GB; Ordy, MJ; Palmer, GC; Radov, LA; Simmons, RD; St Georgiev, V; Strand, JC | 1 |
| Blessing, JA; Buchsbaum, HJ; DiSaia, PJ; McGuire, WP | 1 |
4 review(s) available for isoxazoles and Nervous System Disorders
| Article | Year |
|---|---|
[Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].
Topics: Anticonvulsants; Bipolar Disorder; Calcium Channels, T-Type; Cholinergic Agents; Dopamine Agents; Dyskinesias; Epilepsy; Excitatory Amino Acid Agents; Feeding and Eating Disorders; GABA Agents; Humans; Isoxazoles; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Neuroprotective Agents; Obesity; Parkinson Disease; Randomized Controlled Trials as Topic; Sodium Channels; Treatment Outcome; Voltage-Gated Sodium Channel beta-2 Subunit; Zonisamide | 2009 |
Paliperidone use in the elderly.
Topics: Age Factors; Aged; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Nervous System Diseases; Paliperidone Palmitate; Pyrimidines; Schizophrenia | 2010 |
Selective COX-1 inhibition: A therapeutic target to be reconsidered.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Endothelial Cells; Female; Humans; Isoxazoles; Neoplasms; Nervous System Diseases; Obstetric Labor, Premature; Pain; Pregnancy | 2010 |
Use of anticonvulsants for treatment of neuropathic pain.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Nervous System Diseases; Pain; Phenytoin; Triazines; Zonisamide | 2002 |
5 other study(ies) available for isoxazoles and Nervous System Disorders
| Article | Year |
|---|---|
Parecoxib Protects Mouse Cortical Neurons Against OGD/R Induced Neurotoxicity by Up-Regulating Bcl-2.
Topics: Adenosine Triphosphate; Animals; Cell Death; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2 Inhibitors; Gene Knockdown Techniques; Glucose; Hypoxia, Brain; Isoxazoles; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Nervous System Diseases; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; RNA, Small Interfering; Up-Regulation | 2015 |
Zonisamide: new drug. No advantage in refractory partial epilepsy.
Topics: Anticonvulsants; Double-Blind Method; Drug Approval; Drug Therapy, Combination; Epilepsies, Partial; Fever; France; Humans; Hypersensitivity; Isoxazoles; Kidney Calculi; Meta-Analysis as Topic; Nervous System Diseases; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome; United States | 2007 |
Kainic acid neurotoxicity: in vivo test of two new non-N-methyl-D-aspartate receptor antagonists.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Corpus Striatum; Hippocampus; Isoxazoles; Kainic Acid; Male; Nervous System Diseases; Pyramidal Tracts; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.
Topics: Administration, Oral; Analgesics; Animals; Anticonvulsants; Antifungal Agents; Female; Isoxazoles; Male; Mice; Microbial Sensitivity Tests; Nervous System Diseases; Oxazoles; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Oxazoles | 1986 |